Impact of EU label changes and revised pregnancy prevention programme for oral retinoid containing medicinal products

For more information on this project, please contact the EU PE&PV research network at eupepv@uu.nl.

Project information

  • EU PE&PV research network
  • Specific Contract 02 implementing Framework service contract EMA/2018/28/PE

Full title

Impact of EU label changes and revised pregnancy prevention programme for oral retinoid containing medicinal products: utilization and prescribing trends

Principal investigator

Prof. Dr. Miriam Sturkenboom, 木瓜福利影视 Medical Center Utrecht

Participating organisations

  • Utrecht 木瓜福利影视, The Netherlands - consortium lead
  • UMC Utrecht, The Netherlands - coordinator
  • 木瓜福利影视 of Copenhagen, Denmark 
  • 木瓜福利影视 of Messina, Italy 
  • ARS Toscana, Italy 
  • PHARMO Institute, The Netherlands 
  • AEMPS, Spain 
  • FICF, Spain 

Status

Completed (2022)

Deliverables

Peer-reviewed scientific publications

Dur谩n CE, Riera-Arnau J, Abtahi S, Pajouheshnia R, Hoxhaj V, Gamba M, Alsina E, Martin-Perez M, Garcia-Poza P, Llorente-Garcia A, Gonzalez-Bermejo D, Ib谩nez L, Sabat茅 M, Vidal X, Ballar铆n E, Sanf茅lix-Gimeno G, Rodr铆guez-Bernal C, Peir贸 S, Garc铆a-Sempere A, Sanchez-Saez F, Ientile V, Ingrasciotta Y, Guarneri C, Tanaglia M, Tari M, Herings R, Houben E, Swart-Polinder K, Holthuis E, Huerta C, Gini R, Roberto G, Bartolini C, Paoletti O, Limoncella G, Girardi A, Hyeraci G, Andersen M, Kristiansen SB, Hallgreen CE, Klungel O, Sturkenboom M. Front Pharmacol. 2023 Aug 17;14:1207976. doi: 10.3389/fphar.2023.1207976. PMID: 37663263; PMCID: PMC10469888.